메뉴 건너뛰기




Volumn 30, Issue 2, 2006, Pages 251-264

Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients

Author keywords

Chinese; Clozapine; Plasma level; Treatment resistant schizophrenia

Indexed keywords

CLOZAPINE; LORAZEPAM; NORCLOZAPINE; VALPROIC ACID;

EID: 33644533551     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.10.008     Document Type: Article
Times cited : (48)

References (102)
  • 4
    • 0030698705 scopus 로고    scopus 로고
    • Blood clozapine levels elevated by fluvoxamine: Potential for side effects and lower clozapine dosage
    • S. Armstrong, and J.R. Stephens Blood clozapine levels elevated by fluvoxamine: potential for side effects and lower clozapine dosage J. Clin. Psychiatry 58 1997 499
    • (1997) J. Clin. Psychiatry , vol.58 , pp. 499
    • Armstrong, S.1    Stephens, J.R.2
  • 7
    • 0028246115 scopus 로고
    • Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk
    • C. Barnas, A. Bergant, M. Hummer, A. Saria, and W.W. Fleischacker Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk Am. J. Psychiatry 151 1994 945
    • (1994) Am. J. Psychiatry , vol.151 , pp. 945
    • Barnas, C.1    Bergant, A.2    Hummer, M.3    Saria, A.4    Fleischacker, W.W.5
  • 8
    • 0024358369 scopus 로고
    • A rating scale for drug-induced akathisia
    • T. Barnes A rating scale for drug-induced akathisia Br. J. Psychiatry 154 1989 672 676
    • (1989) Br. J. Psychiatry , vol.154 , pp. 672-676
    • Barnes, T.1
  • 9
    • 0029769679 scopus 로고    scopus 로고
    • The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: A comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate
    • A. Bartoli, S. Xiaodong, G. Gatti, G. Cipolla, R. Marchiselli, and E. Perucca The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate Ther. Drug Monit. 18 1996 586 591
    • (1996) Ther. Drug Monit. , vol.18 , pp. 586-591
    • Bartoli, A.1    Xiaodong, S.2    Gatti, G.3    Cipolla, G.4    Marchiselli, R.5    Perucca, E.6
  • 11
    • 0019433268 scopus 로고
    • Extrapyramidal reactions in Asians
    • R.L. Binder, and R. Levy Extrapyramidal reactions in Asians Am. J. Psychiatry 138 1981 1243 1244
    • (1981) Am. J. Psychiatry , vol.138 , pp. 1243-1244
    • Binder, R.L.1    Levy, R.2
  • 12
    • 0031903147 scopus 로고    scopus 로고
    • Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients
    • J.A. Carrillo, A.G. Herraiz, S.I. Ramos, and J. Benitez Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients J. Clin. Psychopharmacol. 18 1998 311 316
    • (1998) J. Clin. Psychopharmacol. , vol.18 , pp. 311-316
    • Carrillo, J.A.1    Herraiz, A.G.2    Ramos, S.I.3    Benitez, J.4
  • 15
    • 0028908644 scopus 로고
    • Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites
    • D. Centorrino, R.J. Baldessarini, J.G. Flod, J.C. Kando, and F.R. Frankenburg Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites Am. J. Psychiatry 152 1995 610 612
    • (1995) Am. J. Psychiatry , vol.152 , pp. 610-612
    • Centorrino, D.1    Baldessarini, R.J.2    Flod, J.G.3    Kando, J.C.4    Frankenburg, F.R.5
  • 19
    • 0026684314 scopus 로고
    • Neuroleptic prescription for Chinese schizophrenics in Hong Kong
    • H. Chiu, S. Lee, C.M. Leung, and Y.K. Wing Neuroleptic prescription for Chinese schizophrenics in Hong Kong Aust. N. Z. J. Psychiatry 26 1992 262 264
    • (1992) Aust. N. Z. J. Psychiatry , vol.26 , pp. 262-264
    • Chiu, H.1    Lee, S.2    Leung, C.M.3    Wing, Y.K.4
  • 20
    • 0031439716 scopus 로고    scopus 로고
    • Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia
    • S.A. Chong, C.H. Tan, Y.M. Khoo, H.S. Lee, K.E. Wong, F. Ngui, and M. Winslow Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia Ther. Drug Monit. 19 1997 219 223
    • (1997) Ther. Drug Monit. , vol.19 , pp. 219-223
    • Chong, S.A.1    Tan, C.H.2    Khoo, Y.M.3    Lee, H.S.4    Wong, K.E.5    Ngui, F.6    Winslow, M.7
  • 22
    • 0033665791 scopus 로고    scopus 로고
    • A case of pharmacokinetic interference in comedication of clozapine and valproic acid
    • A. Conca, W. Beraus, P. König, and R. Waschgler A case of pharmacokinetic interference in comedication of clozapine and valproic acid Pharmacopsychiatry 33 2000 234 235
    • (2000) Pharmacopsychiatry , vol.33 , pp. 234-235
    • Conca, A.1    Beraus, W.2    König, P.3    Waschgler, R.4
  • 24
    • 0028307888 scopus 로고
    • Disposition of clozapine in man: Lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphism
    • M.L. Dahl, A. Llerena, U. Bondesson, L. Lindström, and L. Bertilsson Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphism Br. J. Clin. Pharmacol. 37 1994 71 74
    • (1994) Br. J. Clin. Pharmacol. , vol.37 , pp. 71-74
    • Dahl, M.L.1    Llerena, A.2    Bondesson, U.3    Lindström, L.4    Bertilsson, L.5
  • 25
    • 0029950811 scopus 로고    scopus 로고
    • Elevated clozapine levels after fluvoxamine initiation
    • J.R. Dequardo, and M. Roberts Elevated clozapine levels after fluvoxamine initiation Am. J. Psychiatry 153 1996 840 841
    • (1996) Am. J. Psychiatry , vol.153 , pp. 840-841
    • Dequardo, J.R.1    Roberts, M.2
  • 27
    • 0028301156 scopus 로고
    • The use of chloral hydrate and sodium amytal during clozapine initiation
    • R.A. Dickson, R. Williams, and T. Dalby The use of chloral hydrate and sodium amytal during clozapine initiation Can. J. Psychiatry 39 1994 132 134
    • (1994) Can. J. Psychiatry , vol.39 , pp. 132-134
    • Dickson, R.A.1    Williams, R.2    Dalby, T.3
  • 30
    • 0036898975 scopus 로고    scopus 로고
    • Is the time of course of clozapine response correlated to the time course of clozapine plasma levels? a one-year prospective study in drug-resistant patients with schizophrenia
    • M. Fabrazzo, S. La Pia, P. Monteleone, G. Esposito, A. Pinto, L. De Simone, R. Bencivenga, and M. Maj Is the time of course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia Neuropsychopharmacolgy 27 2002 1050 1055
    • (2002) Neuropsychopharmacolgy , vol.27 , pp. 1050-1055
    • Fabrazzo, M.1    La Pia, S.2    Monteleone, P.3    Esposito, G.4    Pinto, A.5    De Simone, L.6    Bencivenga, R.7    Maj, M.8
  • 31
    • 0033045133 scopus 로고    scopus 로고
    • Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorder
    • G. Facciolà, A. Avenoso, M.G. Scordo, A.G. Madia, A. Ventimiglia, E. Perucca, and E. Spina Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorder Ther. Drug Monit. 21 1999 341 345
    • (1999) Ther. Drug Monit. , vol.21 , pp. 341-345
    • Facciolà, G.1    Avenoso, A.2    Scordo, M.G.3    Madia, A.G.4    Ventimiglia, A.5    Perucca, E.6    Spina, E.7
  • 32
    • 0025863392 scopus 로고
    • 1-acid glycoprotein concentration in Chinese and Caucasian
    • 1-acid glycoprotein concentration in Chinese and Caucasian Br. J. Clin. Pharmacol. 31 1991 551 552
    • (1991) Br. J. Clin. Pharmacol. , vol.31 , pp. 551-552
    • Feely, J.1    Grimm, T.2
  • 33
    • 0028146698 scopus 로고
    • Potential impact of valproic acid therapy on clozapine disposition
    • P. Finley, and D. Warner Potential impact of valproic acid therapy on clozapine disposition Biol. Psychiatry 36 1994 487 488
    • (1994) Biol. Psychiatry , vol.36 , pp. 487-488
    • Finley, P.1    Warner, D.2
  • 34
    • 0030944756 scopus 로고    scopus 로고
    • Clozapine-induced electroencephalogram changes as a function of clozapine serum levels
    • O. Freudenreich, R.D. Weiner, and J.P. McEvoy Clozapine-induced electroencephalogram changes as a function of clozapine serum levels Biol. Psychiatry 42 1997 132 137
    • (1997) Biol. Psychiatry , vol.42 , pp. 132-137
    • Freudenreich, O.1    Weiner, R.D.2    McEvoy, J.P.3
  • 41
    • 0027740188 scopus 로고
    • Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: Effect of smoking
    • M. Hasegawa, R. Gutierrez-Esteinou, L. Way, and H.Y. Meltzer Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking J. Clin. Psychopharmacol. 13 1993 383 390
    • (1993) J. Clin. Psychopharmacol. , vol.13 , pp. 383-390
    • Hasegawa, M.1    Gutierrez-Esteinou, R.2    Way, L.3    Meltzer, H.Y.4
  • 43
    • 0030825390 scopus 로고    scopus 로고
    • A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia
    • C.J. Hong, J.Y. Chen, H.J. Chiu, and C.B. Sim A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia Int. J. Clin. Psychopharmacol. 12 1997 123 130
    • (1997) Int. J. Clin. Psychopharmacol. , vol.12 , pp. 123-130
    • Hong, C.J.1    Chen, J.Y.2    Chiu, H.J.3    Sim, C.B.4
  • 45
    • 0023812652 scopus 로고
    • Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
    • J. Kane, G. Honigfeld, J. Singer, and H. Meltzer Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine Arch. Gen. Psychiatry 45 1988 789 796
    • (1988) Arch. Gen. Psychiatry , vol.45 , pp. 789-796
    • Kane, J.1    Honigfeld, G.2    Singer, J.3    Meltzer, H.4
  • 49
    • 0030010160 scopus 로고    scopus 로고
    • Fluvoxamine increases the clozapine serum levels significantly
    • H.K. Koponen, E. Leinonen, and U. Lepola Fluvoxamine increases the clozapine serum levels significantly Eur. Neuropsychopharmacol. 6 1996 69 71
    • (1996) Eur. Neuropsychopharmacol. , vol.6 , pp. 69-71
    • Koponen, H.K.1    Leinonen, E.2    Lepola, U.3
  • 53
    • 0035196163 scopus 로고    scopus 로고
    • Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability
    • H.Y. Lane, M.W. Jann, Y.C. Chang, C.C. Chiu, M.C. Huang, S.H. Lee, and W.H. Chang Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability J. Clin. Psychiatry 62 2001 812 817
    • (2001) J. Clin. Psychiatry , vol.62 , pp. 812-817
    • Lane, H.Y.1    Jann, M.W.2    Chang, Y.C.3    Chiu, C.C.4    Huang, M.C.5    Lee, S.H.6    Chang, W.H.7
  • 55
    • 0020597567 scopus 로고
    • Neuroleptic dosage for Asians
    • K.M. Lin, and E. Finder Neuroleptic dosage for Asians Am. J. Psychiatry 140 1983 490 491
    • (1983) Am. J. Psychiatry , vol.140 , pp. 490-491
    • Lin, K.M.1    Finder, E.2
  • 56
    • 0023935333 scopus 로고
    • Haloperidol and prolactin concentrations in Asians and Caucasians
    • K.M. Lin, R.E. Poland, J. Lau, and R.T. Rubin Haloperidol and prolactin concentrations in Asians and Caucasians J. Clin. Psychopharmacol. 8 1988 195 201
    • (1988) J. Clin. Psychopharmacol. , vol.8 , pp. 195-201
    • Lin, K.M.1    Poland, R.E.2    Lau, J.3    Rubin, R.T.4
  • 57
    • 0024435931 scopus 로고
    • Longitudinal assessment of haloperidol dosage and serum concentration in Asian and Caucasian schizophrenic patients
    • K.M. Lin, R.E. Poland, J. Lau, I. Nuccio, K. Matsuda, N. Hathuc, T. Su, and P. fu Longitudinal assessment of haloperidol dosage and serum concentration in Asian and Caucasian schizophrenic patients Am. J. Psychiatry 146 1989 1307 1311
    • (1989) Am. J. Psychiatry , vol.146 , pp. 1307-1311
    • Lin, K.M.1    Poland, R.E.2    Lau, J.3    Nuccio, I.4    Matsuda, K.5    Hathuc, N.6    Su, T.7    Fu, P.8
  • 58
    • 0036246398 scopus 로고    scopus 로고
    • Effectiveness of clozapine in neuroleptic-resistant schizophrenia: Clinical response and plasma concentrations
    • P.M. Llorca, C. Lancon, B. Disdier, J. Farisee, C. Sapin, and P. Auquier Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations J. Psychiatry Neurosci. 27 2002 30 37
    • (2002) J. Psychiatry Neurosci. , vol.27 , pp. 30-37
    • Llorca, P.M.1    Lancon, C.2    Disdier, B.3    Farisee, J.4    Sapin, C.5    Auquier, P.6
  • 59
    • 0028917675 scopus 로고
    • Valproic acid effects on serum concentrations of clozapine and norclozapine
    • L.P. Longo, and C. Salzman Valproic acid effects on serum concentrations of clozapine and norclozapine Am. J. Psychiatry 153 1995 650
    • (1995) Am. J. Psychiatry , vol.153 , pp. 650
    • Longo, L.P.1    Salzman, C.2
  • 60
    • 84920227522 scopus 로고
    • Low frequency of slow debrisoquine hydroxylation in a native Chinese population
    • Y.C. Lou, L. Ying, L. Bertilsson, and F. Sjöqvist Low frequency of slow debrisoquine hydroxylation in a native Chinese population Lancet 10 1987 852 853
    • (1987) Lancet , vol.10 , pp. 852-853
    • Lou, Y.C.1    Ying, L.2    Bertilsson, L.3    Sjöqvist, F.4
  • 61
    • 0033861422 scopus 로고    scopus 로고
    • Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients
    • M.L. Lu, H.Y. Lane, K.P. Chen, M.W. Jann, M.H. Su, and W.H. Chang Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients J. Clin. Psychiatry 61 2000 594 599
    • (2000) J. Clin. Psychiatry , vol.61 , pp. 594-599
    • Lu, M.L.1    Lane, H.Y.2    Chen, K.P.3    Jann, M.W.4    Su, M.H.5    Chang, W.H.6
  • 62
    • 0001190858 scopus 로고
    • Appendix A. Manual for expanded for brief psychiatric rating scale (BPRS)
    • D. Lukoff, K.H. Nuechterlein, and J. Ventura Appendix A. Manual for expanded for brief psychiatric rating scale (BPRS) Schizophr. Bull. 12 1986 594 602
    • (1986) Schizophr. Bull. , vol.12 , pp. 594-602
    • Lukoff, D.1    Nuechterlein, K.H.2    Ventura, J.3
  • 63
    • 9344235447 scopus 로고    scopus 로고
    • Clozapine dosage, serum levels, efficacy, and side-effect profiles: A comparison of Korean-American and Caucasian patients
    • K.T. Matsuda, C.C. Man, M.L. Keg, M.W. Smith, A.S. Young, and J.A. Adams Clozapine dosage, serum levels, efficacy, and side-effect profiles: a comparison of Korean-American and Caucasian patients Psychopharmacol. Bull. 32 1996 253 257
    • (1996) Psychopharmacol. Bull. , vol.32 , pp. 253-257
    • Matsuda, K.T.1    Man, C.C.2    Keg, M.L.3    Smith, M.W.4    Young, A.S.5    Adams, J.A.6
  • 65
  • 66
    • 0035195730 scopus 로고    scopus 로고
    • Individual changes in clozapine levels after smoking cessation: Results and a predictive model
    • J.M. Meyer Individual changes in clozapine levels after smoking cessation: results and a predictive model J. Clin. Psychopharmacol. 21 2001 569 574
    • (2001) J. Clin. Psychopharmacol. , vol.21 , pp. 569-574
    • Meyer, J.M.1
  • 67
    • 0026078295 scopus 로고
    • Effect of phenytoin on plasma clozapine concentrations in two patients
    • D.D. Miller Effect of phenytoin on plasma clozapine concentrations in two patients J. Clin. Psychiatry 52 1991 23 25
    • (1991) J. Clin. Psychiatry , vol.52 , pp. 23-25
    • Miller, D.D.1
  • 68
    • 0027937972 scopus 로고
    • Plasma clozapine concentrations as a predictor of clinical response: A follow-up study
    • D.D. Miller, P. Fleming, and T.L. Holman Plasma clozapine concentrations as a predictor of clinical response: a follow-up study J. Clin. Psychiatry 55 1994 117 121
    • (1994) J. Clin. Psychiatry , vol.55 , pp. 117-121
    • Miller, D.D.1    Fleming, P.2    Holman, T.L.3
  • 69
    • 0022178173 scopus 로고
    • Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations
    • K. Nakamura, F. Goto, W.A. Ray, C.B. McAllister, E. Jacqz, G.R. Wilkinson, and R.A. Branch Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations Clin. Pharmacol. Ther. 38 1985 402 408
    • (1985) Clin. Pharmacol. Ther. , vol.38 , pp. 402-408
    • Nakamura, K.1    Goto, F.2    Ray, W.A.3    McAllister, C.B.4    Jacqz, E.5    Wilkinson, G.R.6    Branch, R.A.7
  • 70
    • 0029617261 scopus 로고
    • CSF and serum concentrations of clozapine and its demethyl metabolite: A pilot study
    • C. Nordin, B. Almé, and U. Bondesson CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study Psychopharmacology 122 1995 104 107
    • (1995) Psychopharmacology , vol.122 , pp. 104-107
    • Nordin, C.1    Almé, B.2    Bondesson, U.3
  • 73
    • 0036277478 scopus 로고    scopus 로고
    • Relation of blood counts during clozapine treatment to serum concentrations of clozapine and nor-clozapine
    • L.K. Oyewumi, Z.Z. Cernovsky, D.J. Freeman, and D.L. Streiner Relation of blood counts during clozapine treatment to serum concentrations of clozapine and nor-clozapine Can. J. Psychiatry 47 2002 257 261
    • (2002) Can. J. Psychiatry , vol.47 , pp. 257-261
    • Oyewumi, L.K.1    Cernovsky, Z.Z.2    Freeman, D.J.3    Streiner, D.L.4
  • 75
    • 0026068791 scopus 로고
    • Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients
    • P.J. Perry, D.D. Miller, S.V. Arndt, and R.J. Cadoret Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients Am. J. Psychiatry 148 1991 231 235
    • (1991) Am. J. Psychiatry , vol.148 , pp. 231-235
    • Perry, P.J.1    Miller, D.D.2    Arndt, S.V.3    Cadoret, R.J.4
  • 76
    • 0032532712 scopus 로고    scopus 로고
    • Relationship between patient variables and plasma clozapine concentrations: A dosing nomogram
    • P.J. Perry, K.A. Bever, S. Arndt, and M.D. Combs Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram Biol. Psychiatry 434 1998 733 738
    • (1998) Biol. Psychiatry , vol.434 , pp. 733-738
    • Perry, P.J.1    Bever, K.A.2    Arndt, S.3    Combs, M.D.4
  • 77
    • 0026772116 scopus 로고
    • Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine
    • D. Pickar, R.R. Owen, R.E. Litman, E. Konicki, R. Guterrez, and M.H. Rapaport Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine Arch. Gen. Psychiatry 49 1992 345 353
    • (1992) Arch. Gen. Psychiatry , vol.49 , pp. 345-353
    • Pickar, D.1    Owen, R.R.2    Litman, R.E.3    Konicki, E.4    Guterrez, R.5    Rapaport, M.H.6
  • 81
    • 0033378177 scopus 로고    scopus 로고
    • How long to wait for a response to clozapine: A comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia
    • R. Rosenheck, D. Evans, L. Herz, J. Cramer, W. Xu, J. Thomas, W. Henderson, and D. Charney How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia Schizophr. Bull. 25 1999 709 719
    • (1999) Schizophr. Bull. , vol.25 , pp. 709-719
    • Rosenheck, R.1    Evans, D.2    Herz, L.3    Cramer, J.4    Xu, W.5    Thomas, J.6    Henderson, W.7    Charney, D.8
  • 82
    • 0032897189 scopus 로고    scopus 로고
    • Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia
    • and the Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia D.
    • R. Rosenheck, L. Dunn, M. Peszke, J. Cramer, W. Xu, J. Thomas, D. Charney and the Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia Am. J. Psychiatry 156 1999 88 93
    • (1999) Am. J. Psychiatry , vol.156 , pp. 88-93
    • Rosenheck, R.1    Dunn, L.2    Peszke, M.3    Cramer, J.4    Xu, W.5    Thomas, J.6    Charney7
  • 83
    • 0001851257 scopus 로고
    • The UKU side effect's rating scale
    • Scandinavian Society of Psychopharmacology Committee of Clinical Investigations (UKU) The UKU side effect's rating scale Acta Psychiatr. Scand. 334 1987 81 100 (Suppl.)
    • (1987) Acta Psychiatr. Scand. , vol.334 , pp. 81-100
  • 84
    • 0032711713 scopus 로고    scopus 로고
    • Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients
    • N.H. Seppälä, E.V.J. Leinonen, M.L. Lehtonen, and K.T. Kivist Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients Pharmacol. Toxicol. 85 1999 244 246
    • (1999) Pharmacol. Toxicol. , vol.85 , pp. 244-246
    • Seppälä, N.H.1    Leinonen, E.V.J.2    Lehtonen, M.L.3    Kivist, K.T.4
  • 85
    • 48249153186 scopus 로고
    • Intraclass correlations: Uses in assessing rater reliability
    • P.E. Shrout, and J.L. Fleiss Intraclass correlations: uses in assessing rater reliability Psychol. Bull. 86 1979 420 428
    • (1979) Psychol. Bull. , vol.86 , pp. 420-428
    • Shrout, P.E.1    Fleiss, J.L.2
  • 86
    • 0014723449 scopus 로고
    • A rating scale for extrapyramidal side effects
    • G. Simpson, and J.S.W. Angus A rating scale for extrapyramidal side effects Acta Psychiatr. Scand. 212 1970 9 11 (Suppl.)
    • (1970) Acta Psychiatr. Scand. , vol.212 , pp. 9-11
    • Simpson, G.1    Angus, J.S.W.2
  • 87
    • 0002310994 scopus 로고    scopus 로고
    • Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics
    • E. Spina, A. Avenoso, G. Facciolä, M.G. Scordo, M. Ancione, A.G. Madia, A. Ventimiglia, and E. Perucca Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics Psychopharmacology 148 2000 83 89
    • (2000) Psychopharmacology , vol.148 , pp. 83-89
    • Spina, E.1    Avenoso, A.2    Facciolä, G.3    Scordo, M.G.4    Ancione, M.5    Madia, A.G.6    Ventimiglia, A.7    Perucca, E.8
  • 88
    • 0022569655 scopus 로고
    • Neuroleptic dosage for Asians: A failure to replicate
    • J.J. Sramek, M.A. Sayles, and G.M. Simpson Neuroleptic dosage for Asians: a failure to replicate Am. J. Psychiatry 153 1986 535 536
    • (1986) Am. J. Psychiatry , vol.153 , pp. 535-536
    • Sramek, J.J.1    Sayles, M.A.2    Simpson, G.M.3
  • 89
    • 0028925217 scopus 로고
    • Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine
    • A. Szegedi, J. Wiesner, and C. Hiemke Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine J. Clin. Psychopharmacol. 15 1995 141 143
    • (1995) J. Clin. Psychopharmacol. , vol.15 , pp. 141-143
    • Szegedi, A.1    Wiesner, J.2    Hiemke, C.3
  • 90
    • 0032863283 scopus 로고    scopus 로고
    • Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: Drug monitoring and tolerability data from a prospective clinical trial
    • A. Szegedi, I. Anghelescu, J. Wiesner, S. Schlegel, H. Weigmann, S. Härtter, C. Hiemke, and H. Wetzel Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial Pharmacopsychiatry 32 1999 148 153
    • (1999) Pharmacopsychiatry , vol.32 , pp. 148-153
    • Szegedi, A.1    Anghelescu, I.2    Wiesner, J.3    Schlegel, S.4    Weigmann, H.5    Härtter, S.6    Hiemke, C.7    Wetzel, H.8
  • 91
    • 0027483444 scopus 로고
    • Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients; A single-dose preliminary study
    • C.H. Tan, B.I. Low, L.L. Ng, Y.M. Khoo, and H.S. Lee Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients; a single-dose preliminary study Ther. Drug Monit. 15 1993 108 112
    • (1993) Ther. Drug Monit. , vol.15 , pp. 108-112
    • Tan, C.H.1    Low, B.I.2    Ng, L.L.3    Khoo, Y.M.4    Lee, H.S.5
  • 92
    • 0017330153 scopus 로고
    • Clozapine treatment of schizophrenic patients: Plasma concentration and coagulation factors
    • M. Thorup, and R. Fog Clozapine treatment of schizophrenic patients: plasma concentration and coagulation factors Acta Psychiatr. Scand. 66 1977 123 126
    • (1977) Acta Psychiatr. Scand. , vol.66 , pp. 123-126
    • Thorup, M.1    Fog, R.2
  • 93
    • 0029906397 scopus 로고    scopus 로고
    • EEG abnormalities in clozapine-treated schizophrenia patients
    • I.A. Treves, and M.Y. Neufeld EEG abnormalities in clozapine-treated schizophrenia patients Eur. Neuropsychopharmacol. 6 1996 93 94
    • (1996) Eur. Neuropsychopharmacol. , vol.6 , pp. 93-94
    • Treves, I.A.1    Neufeld, M.Y.2
  • 94
    • 0026441418 scopus 로고
    • Drug distribution between blood and brain as a determinant of antipsychotic drug effects
    • T. Tsuneizumi, S.M. Babb, and B.M. Cohen Drug distribution between blood and brain as a determinant of antipsychotic drug effects Biol. Psychiatry 32 1992 817 824
    • (1992) Biol. Psychiatry , vol.32 , pp. 817-824
    • Tsuneizumi, T.1    Babb, S.M.2    Cohen, B.M.3
  • 95
    • 0032955464 scopus 로고    scopus 로고
    • Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine
    • M. Tugnait, E.M. Hawes, G. McKay, M. Eichelbaum, and K.K. Midha Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine Chem.-Biol. Interact. 118 1999 171 189
    • (1999) Chem.-Biol. Interact. , vol.118 , pp. 171-189
    • Tugnait, M.1    Hawes, E.M.2    McKay, G.3    Eichelbaum, M.4    Midha, K.K.5
  • 96
    • 0037339287 scopus 로고    scopus 로고
    • The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement
    • J. Van der Weide, L.S.W. Steijns, and M.J.M. Van Weelden The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement Pharmacogenetics 13 2003 169 172
    • (2003) Pharmacogenetics , vol.13 , pp. 169-172
    • Van Der Weide, J.1    Steijns, L.S.W.2    Van Weelden, M.J.M.3
  • 97
    • 0029903903 scopus 로고    scopus 로고
    • Response of patients with treatment-resistant schizophrenia to clozapine within three serum level ranges
    • C. VanderZwaag, M. McGee, J.P. McEvoy, O. Freudenreich, W.H. Wilson, and T.B. Cooper Response of patients with treatment-resistant schizophrenia to clozapine within three serum level ranges Am. J. Psychiatry 153 1996 1579 1584
    • (1996) Am. J. Psychiatry , vol.153 , pp. 1579-1584
    • Vanderzwaag, C.1    McGee, M.2    McEvoy, J.P.3    Freudenreich, O.4    Wilson, W.H.5    Cooper, T.B.6
  • 100
    • 0029899665 scopus 로고    scopus 로고
    • Time required for initial improvement during clozapine treatment of refractory schizophrenia
    • W.H. Wilson Time required for initial improvement during clozapine treatment of refractory schizophrenia Am. J. Psychiatry 153 1996 951 952
    • (1996) Am. J. Psychiatry , vol.153 , pp. 951-952
    • Wilson, W.H.1
  • 102
    • 0025326592 scopus 로고
    • Differences in plasma binding of drugs between Caucasians and Chinese subjects
    • H.H. Zhou, A. Adedoyin, and G.R. Wilkinson Differences in plasma binding of drugs between Caucasians and Chinese subjects Pharmacokinet. Drug Dispos. 48 1990 10 17
    • (1990) Pharmacokinet. Drug Dispos. , vol.48 , pp. 10-17
    • Zhou, H.H.1    Adedoyin, A.2    Wilkinson, G.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.